Header Logo

Connection

MICHAEL R MIGDEN to Administration, Oral

Back to Details
This is a "connection" page, showing publications MICHAEL R MIGDEN has written about Administration, Oral.
MICHAEL R MIGDEN
Connection Strength
0.042
Administration, Oral
  1. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol. 2015 Jun; 72(6):1021-6.e8.
    View in: PubMed
    Score: 0.023
  2. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012 Jun 07; 366(23):2171-9.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.